Key points are not available for this paper at this time.
Breast cancer in men accounts for about 1% of all breast cancers and is mainly estrogen-receptor–positive. Few prospective studies of treatment in men have been performed, so management is based largely on extrapolation from results in postmenopausal women.
Sharon H. Giordano (Wed,) studied this question.